Taconic Capital Advisors LP Axonics, Inc. Transaction History

Taconic Capital Advisors LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$69.41 - $70.98 $15.6 Million - $16 Million	-225,000 Closed	0 $0
Q4 2024 Feb 14, 2025	BUY	$69.41 - $70.98 $15.6 Million - $16 Million	225,000 New	225,000 $15.5 Billion
Q3 2024 Feb 14, 2025	SELL	$67.3 - $69.67 $9.09 Million - $9.41 Million	-135,000 Closed	0 $0
Q2 2024 Feb 14, 2025	BUY	$66.47 - $69.65 $8.97 Million - $9.4 Million	135,000 New	135,000 $9.08 Billion

5.03M

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Taconic Capital Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Taconic Capital Advisors LP with notifications on news.